BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Medtronic
Express Scripts
Healthtrust
QuintilesIMS
Chubb
Chinese Patent Office
US Department of Justice
Farmers Insurance

Generated: January 17, 2018

DrugPatentWatch Database Preview

DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Dextrose 5% And Sodium Chloride 0.225% In Plastic Container patents expire, and when can generic versions of Dextrose 5% And Sodium Chloride 0.225% In Plastic Container launch?

Dextrose 5% And Sodium Chloride 0.225% In Plastic Container is a drug marketed by Abbott and Icu Medical Inc and is included in two NDAs.

The generic ingredient in DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.
Summary for DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
Pharmacology for DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019482-001 Oct 4, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Icu Medical Inc DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 017606-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cerilliant
Citi
Julphar
McKinsey
Medtronic
Chinese Patent Office
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot